 |
MN14 monoclonal antibody to carcinoembryonic antigen |
|---|---|
| Trade Name | Cea-Cide |
| Orphan Indication | Pancreatic cancer |
| USA Market Approval | USA |
| USA Designation Date | 1998-11-24 00:00:00 |
| Sponsor | Immunomedics, Inc.;300 The American Road;Morris Plains, New Jersey, 07950 |
